EBMT-EHA CAR-T 2019 | CAR-T19: A novel model of recognition

Jürgen Kuball

Jürgen Kuball MD, PhD, from the University Medical Center, Utrecht, Amsterdam, discusses the mode of recognition of T-cells engineered to express γδT cell receptor (TEGs), and the way in which this receptor (γδT) allows for the recognition of cancer cells via there early metabolic changes. Recorded at the 1st European CAR T-Cell Meeting in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video